Why the study?
Helix retraction during septal lead deployment can complicate LBBP procedures with extendable-retractable helix leads, but clinical performance data on a novel helix locking tool remain limited.
Comparison
Helix locking tool used during septal deployment of a stylet-driven lead
Design
Prospective multicenter registry
Follow-up
24 hours
Key result
The use of a helix locking tool during left bundle branch pacing was associated with a 90.8% procedural success rate, complete absence of helix retraction, and no tool-related acute adverse events.
Authors
Loading...
May facilitate LBBP by reducing helix retraction; hypothesis-generating pending randomized confirmation.
Observational (n=87)
Yes
The use of a helix locking tool during left bundle branch pacing with stylet-driven leads is feasible and safe, achieving high procedural success without HLT-related acute complications.
Menéndez et al. (2026) conducted an observational in Bradycardia or heart failure requiring cardiac device implantation (n=87). Helix locking tool (HLT) was evaluated on Freedom from acute adverse events related to the HLT during the procedure or within 24 hours after implantation. The use of a helix locking tool during left bundle branch pacing was associated with a 90.8% procedural success rate, complete absence of helix retraction, and no tool-related acute adverse events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: